reckittbenckiser
Reckitt Benckiser Group Plc (LON:RKT) reported underlying revenue of £12.9bn, excluding the sold Chinese Infant Nutrition business (IFCN China). This was up 3.3% on a constant currency, like-for-like basis (LFL) and was ahead of expectations. Performance was driven by improved pricing and sales mix, though volumes also rose slightly. Q4 2021 hedge fund letters, conferences and more Excluding IFCN China, underlying operating profits fell 2.6% to £2.9bn. That was largely due to cost inflation in the region of 11%. The group’s targeting LFL revenue growth between 1-4% for 2022. Despite CEO Laxman...
ValueWalk
Reckitt Benckiser Group Plc (LON:RKT)’s third quarter like-for-like (LFL) revenue rose 3.3%, with net revenue reaching £3.3bn. Trading has been better than Reckitt expected. Q3 2021 hedge fund letters, conferences and more Growth came from a balance between volume and price increases, while LFLs were up in all divisions and geographies, with North America the strongest region. Full year guidance has been upgraded, with revenue expected to grow 1-3%. Despite ongoing cost inflation, margin guidance remains unchanged. The shares were up 5% following the announcement. Reckitt Benckiser Sees Improv...
ValueWalk
First half like-for-like (LFL) revenue came in at £6.3bn, excluding the for sale Chinese Infant Nutrition business, a 3.7% annual increase. Changes in pricing and sales mix were behind revenue growth, though volumes also rose slightly. Operating profits declined 5% to £1.4bn, reflecting increased investment and cost inflation. Q2 2021 hedge fund letters, conferences and more The group plans price rises in the second half to cope with the rising costs but expects full year margins to decline between 0.4 and 0.9 percentage points. The board recommended an interim dividend of 73p. The shares were...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら